Auto-Captioning Glasses for Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population.
Participants will be asked to:
* Use the glasses at their discretion for 12 weeks
* Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews
Who Is on the Research Team?
Vanessa Merker, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are enrolled, consent is obtained, and baseline data is collected
Treatment
Participants use auto-captioning glasses at their discretion and provide feedback
Follow-up
Participants complete final surveys and interviews, and return the glasses
What Are the Treatments Tested in This Trial?
Interventions
- Auto-Captioning Glasses
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Adults with a clinical diagnosis of NF2-SWN and self reported hearing loss will use the auto-captioning glasses for 12 weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.